← Back to all protocols
22

Acute Hypokalaemia — AdultElectrolyte Emergencies

1 · Quick ED Reference

ECG
↓
Assess severity / symptoms
↓
Check Mg²⁺ + renal function
↓
Identify the cause
↓
Oral K⁺ if appropriate
↓
IV K⁺ if severe, symptomatic, ECG changes, or oral unsuitable
↓
Correct Mg²⁺
↓
Recheck K⁺ / ECG
↓
Monitor for arrhythmia and overcorrection
↓
Treat the underlying cause

2 · Initial Assessment

  • ABCDE approach
  • Assess symptoms and haemodynamic stability
  • 12-lead ECG
  • Cardiac monitoring when indicated
  • Secure IV access if the hypokalaemia is significant/severe or the patient is symptomatic
  • If pseudohypokalaemia or a laboratory error is suspected, repeat the sample — but do not delay treatment of significant or symptomatic hypokalaemia while waiting
  • Check: potassium, magnesium, sodium, calcium, renal function, bicarbonate/acid–base status, glucose, and phosphate where clinically appropriate
  • Always check magnesium in significant or unexplained hypokalaemia.
  • Related EMOnCall protocols: Acute Hyperkalaemia — Adult · Acute Hypomagnesaemia — Adult

3 · Severity Classification

  • Mild: K⁺ 3.0–3.4 mmol/L — usually asymptomatic
  • Moderate: K⁺ 2.5–2.9 mmol/L — weakness, lethargy, constipation; arrhythmia risk begins to rise
  • Severe: K⁺ <2.5 mmol/L — muscle weakness/necrosis, significant arrhythmia risk
  • Sources vary slightly on the exact mild/moderate boundary (some place it at 3.5 rather than 3.4 mmol/L) — treat these as approximate bands, not hard cut-offs
  • Also distinguish: asymptomatic stable hypokalaemia vs symptomatic hypokalaemia vs ECG changes present vs severe hypokalaemia vs ongoing potassium losses vs patients at high arrhythmia risk (e.g. structural heart disease, QT-prolonging drugs, digoxin, acute coronary syndrome)
  • Treatment is driven by this whole picture, not the potassium number alone

4 · ECG Features

  • Flattened T waves
  • ST segment depression
  • Prominent U waves
  • Apparent QT/QU prolongation
  • Ventricular ectopy
  • Atrial arrhythmias
  • Ventricular tachyarrhythmias
  • Bradyarrhythmias in severe cases
  • Severe hypokalaemia can cause life-threatening arrhythmias.
  • ECG findings may be absent despite clinically important hypokalaemia — a normal ECG does not exclude a dangerous potassium level

5 · When to Give Urgent IV Potassium

  • URGENT / IV REPLACEMENT should be considered when there is:
  • Severe hypokalaemia (K⁺ <2.5 mmol/L)
  • Significant symptoms (marked weakness, paralysis, respiratory muscle weakness)
  • ECG changes or arrhythmia
  • Inability to tolerate oral replacement (vomiting, nil by mouth, malabsorption)
  • Ongoing significant potassium losses
  • Any situation where rapid correction is clinically necessary
  • Oral replacement is preferred whenever the patient can take it safely and correction does not need to be rapid — IV replacement is reserved for the indications above, not used routinely because it is faster

6 · Oral Potassium Replacement

  • Preferred for: mild-to-moderate, asymptomatic or minimally symptomatic hypokalaemia in a patient who can safely take oral medication
  • Commonly used preparations: effervescent potassium tablets (e.g. Sando-K®, 12 mmol potassium per tablet); oral potassium solution (7.5% = 1 mmol/mL); modified-release potassium tablets (~8 mmol per tablet, generally less preferred due to GI tolerability)
  • Dose — refers to mmol of potassium, not tablet count: approximately 24 mmol, 2–3 times daily for mild hypokalaemia, or 24–36 mmol, 3–4 times daily for moderate hypokalaemia (e.g. 2 effervescent tablets three times daily ≈ 72 mmol/day) — adjust to response and local formulary
  • Administration: give with or after food to reduce GI upset; dissolve effervescent preparations fully in water
  • Limitations: large doses are limited by nausea, vomiting and poor tolerability/compliance; not suitable for severe hypokalaemia, patients who are nil by mouth, or where immediate correction is required
  • Repeat potassium to confirm response — typically checked daily during oral replacement until the level normalises

7 · IV Potassium Replacement — Safety Critical

  • NEVER GIVE IV POTASSIUM AS A RAPID IV PUSH/BOLUS.
  • USE AN INFUSION PUMP.
  • Preferred salt: potassium chloride, using a commercially premixed, ready-to-use, glucose-free solution wherever possible — glucose stimulates insulin release and can transiently lower serum potassium further, working against replacement. Avoid using high-strength (≥10%) potassium chloride concentrate directly
  • Maximum concentration via a peripheral line: 40 mmol/L — higher concentrations cause vein irritation, pain and phlebitis
  • Maximum routine infusion rate: 10 mmol/hour
  • Higher rate (up to 20 mmol/hour): may be considered for severe or urgent replacement, but only with continuous cardiac (ECG) monitoring, in an appropriately monitored area (resus/HDU/ICU), and ideally after senior review
  • Example severe regimen: 40 mmol potassium chloride in 1 litre 0.9% sodium chloride, infused over 6 hours (≈6.7 mmol/hour) — adjust rate and volume to clinical severity and fluid status
  • Central line: higher concentrations may be used with central venous access, an infusion pump, and continuous ECG monitoring — this needs specialist/senior input and is not routine ED practice
  • Vascular access: a secure, free-flowing line is essential; monitor the infusion site regularly for pain, swelling or extravasation
  • Renal impairment: use lower doses and replace with extra caution, because of the risk of overshoot into hyperkalaemia — recheck potassium more frequently and involve a senior/renal opinion
  • Repeat potassium: recheck at approximately 6 hours (or sooner if there are ECG changes or a high infusion rate) and again at 24 hours, adjusting further replacement to the result

8 · Correct Magnesium Deficiency

  • Hypomagnesaemia commonly accompanies hypokalaemia, and magnesium deficiency can make hypokalaemia refractory to potassium replacement until magnesium is corrected
  • Check magnesium in any significant or unexplained hypokalaemia
  • Severity (serum magnesium): mild 0.5–0.7 mmol/L; severe <0.5 mmol/L
  • Severe/symptomatic hypomagnesaemia: an initial dose of magnesium sulfate 5 g (20 mmol) IV may be given, with further replacement guided by repeat levels (up to a cumulative 40 g/160 mmol may occasionally be needed over several days in severe, ongoing deficiency — under specialist guidance)
  • Infusion rate: typically 1–2 g/hour (4–8 mmol/hour), not exceeding a maximum of 9 g/hour (36 mmol/hour)
  • Concentration limits: peripheral line maximum 5–10% magnesium sulfate solution; central line maximum 20% — the 50% concentrate must always be diluted before use
  • Cardiac monitoring: recommended when giving IV magnesium to a patient with severe symptoms such as tetany, seizures, or arrhythmias
  • Renal impairment: reduce IV magnesium doses by 25–50% in mild-to-moderate renal impairment; seek specialist advice in CKD stage 4–5, AKI, dialysis or transplant patients — oral magnesium does not need dose adjustment
  • Torsades de pointes / peri-arrest ventricular arrhythmia is treated differently and faster than routine replacement above — see section 12 (Arrhythmia)

9 · Choose Oral vs IV — Quick Decision Algorithm

K⁺ low → ECG + symptoms → check Mg²⁺ + renal function
↓
Mild + asymptomatic + stable → oral K⁺ + treat the cause
↓
Moderate / symptomatic → oral ± IV depending on clinical context
↓
Severe / ECG changes / arrhythmia → monitor + urgent IV K⁺ + Mg²⁺ correction

10 · Find and Treat the Cause

  • GI losses: vomiting; diarrhoea; laxative use; nasogastric suction
  • Renal losses: loop diuretics; thiazide diuretics; mineralocorticoid excess; renal tubular disorders
  • Redistribution (into cells): insulin; beta-agonists; alkalosis; periodic paralysis
  • Reduced intake: poor oral intake; malnutrition
  • Other: hypomagnesaemia; alcohol-related nutritional deficiency; certain chemotherapy/drugs
  • Medication review: identify and reassess any medications contributing to potassium loss alongside the causes above

12 · Special Situations

  • DKA: total-body potassium may be substantially depleted despite an initially normal or even high serum potassium (due to acidosis and insulin deficiency) — replacement must follow the relevant DKA protocol; do not give potassium blindly without considering the serum level and renal function
  • Digoxin toxicity: hypokalaemia increases the risk of digoxin-related arrhythmia — correct potassium carefully rather than in a simplistic or rushed way, considering the overall clinical picture and digoxin level
  • Acute coronary syndrome: hypokalaemia raises arrhythmia risk in the peri-infarct period — a higher target potassium may be appropriate in high-risk cardiac patients; follow local cardiology practice
  • Arrhythmia: continuous cardiac monitoring, urgent potassium and magnesium correction, and senior/critical care involvement where appropriate. Torsades de pointes / pulseless ventricular tachycardia: give magnesium sulfate 2 g (8 mmol) IV as a rapid bolus over 1–2 minutes — this specific peri-arrest indication is an exception to the general 'no rapid IV push' rule, which applies to potassium, not to magnesium in this scenario

13 · Monitoring

  • Repeat serum potassium: per section 7 (approximately 6-hourly during IV replacement, then at 24 hours) or daily during oral replacement until normalised
  • Magnesium: recheck alongside potassium, especially if initially low or if potassium is proving refractory to replacement
  • Renal function: monitor throughout, particularly if replacement doses are significant or renal function is abnormal
  • ECG / cardiac rhythm: continuous monitoring during higher-rate IV replacement (>10 mmol/hour), in symptomatic patients, or where ECG changes are present
  • Infusion-site monitoring: check regularly for pain, swelling or extravasation during peripheral IV replacement
  • Frequency of monitoring should be individualised to severity, infusion rate, route, renal function, ECG findings and ongoing potassium losses — increase monitoring frequency for any of these that are more severe
  • When to stop/slow replacement: potassium rising faster than expected, potassium approaching or reaching the normal/high range, new ECG changes suggestive of hyperkalaemia, or infusion-site problems

14 · Renal Impairment

  • RENAL FAILURE / OLIGURIA = HIGH RISK OF POTASSIUM OVERCORRECTION.
  • Use lower replacement doses where appropriate
  • Reassess renal function regularly during replacement
  • Repeat potassium more frequently than in patients with normal renal function
  • Avoid routine aggressive replacement without senior or renal input in significant renal impairment

15 · Disposition

  • Potential discharge: mild/stable, asymptomatic hypokalaemia; cause identified and corrected; potassium safely improving; reliable follow-up available; no significant ECG abnormality
  • Admission: significant/severe hypokalaemia; symptomatic patients; ECG abnormalities; ongoing potassium losses; significant comorbidity; inability to safely replace orally; recurrent or refractory hypokalaemia
  • ICU/HDU / senior review: malignant arrhythmia; haemodynamic instability; severe electrolyte abnormality; need for high-rate IV replacement; complex underlying illness

16 · Red Flags — Urgent Senior / Critical Care Review

  • Severe hypokalaemia
  • ECG changes
  • Ventricular arrhythmia
  • Significant muscle weakness/paralysis
  • Respiratory muscle weakness
  • Ongoing rapid potassium losses
  • Significant hypomagnesaemia
  • Renal dysfunction
  • Inability to safely administer replacement
  • Refractory hypokalaemia

17 · Safety Warnings

  • DO NOT GIVE IV POTASSIUM AS A RAPID IV PUSH.
  • USE AN INFUSION PUMP.
  • CHECK RENAL FUNCTION BEFORE REPLACEMENT.
  • CHECK MAGNESIUM.
  • RECHECK POTASSIUM AFTER SIGNIFICANT REPLACEMENT.
  • CONTINUOUS ECG MONITORING WHEN INDICATED.
← Back to all protocols